Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 725 of 833 entries
View as:

Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT01998139 Org: User:
Start: 07/31/13 End: 02/28/19 Due: 02/28/20

Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00328887 Org: User:
Start: 11/30/04 End: 07/31/10 Due: 07/31/11

COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function

Phase: N/A Priority: Normal
NCT ID: NCT01974154 Org: User:
Start: 12/31/13 End: 05/31/19 Due: 05/31/20

Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00320164 Org: User:
Start: 01/31/06 End: 01/31/08 Due: 01/31/09

Biological Therapy in Treating Patients With Primary or Advanced Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00003067 Org: User:
Start: 07/31/97 End: - Due: -

Roux-en-Y-Gastric Bypass vs. Lifestyle Modification and Medical Therapy in the Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01231308 Org: User:
Start: 10/31/10 End: 10/31/14 Due: 10/31/15

Safety and Efficacy of Eltrombopag at Escalated Doses

Phase: N/A Priority: Normal
NCT ID: NCT01880047 Org: User:
Start: 02/28/13 End: 10/16/17 Due: 10/16/18

In Vitro Maturation (IVM) of Human Oocytes

Phase: N/A Priority: Normal
NCT ID: NCT01550861 Org: User:
Start: 02/15/12 End: 09/18/23 Due: 09/18/24

Ramipril for the Treatment of Oligospermia

Phase: N/A Priority: Normal
NCT ID: NCT01856361 Org: User:
Start: 07/31/13 End: 06/30/16 Due: 06/30/17

Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries

Phase: N/A Priority: Normal
NCT ID: NCT00801996 Org: User:
Start: 09/30/08 End: 09/30/09 Due: 09/30/10

A Randomized Trial: Changing Behavior in Post-Angioplasty Patients

Phase: N/A Priority: Normal
NCT ID: NCT00248846 Org: User:
Start: 10/31/04 End: 07/31/11 Due: 07/31/12

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04149821 Org: User:
Start: 02/10/21 End: 06/09/22 Due: 06/09/23

What Influences Physicians' Decisions - Statistics or Stories?

Phase: N/A Priority: Normal
NCT ID: NCT02048982 Org: User:
Start: 02/28/14 End: 12/31/15 Due: 12/31/16

CPX-351+GO in Subjects 55 Years Old, or Older, With AML

Phase: N/A Priority: Normal
NCT ID: NCT03878927 Org: User:
Start: 08/23/19 End: 09/01/22 Due: 09/01/23

Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions

Phase: N/A Priority: Normal
NCT ID: NCT02540434 Org: User:
Start: 10/31/15 End: 12/31/17 Due: 12/31/18

Impact of Escitalopram on Sperm DNA Fragmentation

Phase: N/A Priority: Normal
NCT ID: NCT03527043 Org: User:
Start: 10/01/17 End: 05/31/24 Due: 05/31/25

Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both

Phase: N/A Priority: Normal
NCT ID: NCT00738413 Org: User:
Start: 08/31/08 End: 12/31/09 Due: 12/31/10

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

Phase: N/A Priority: Normal
NCT ID: NCT00645385 Org: User:
Start: 06/30/07 End: 06/01/11 Due: 06/01/12

Delirium in Children Undergoing Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04937400 Org: User:
Start: 07/12/21 End: 07/31/26 Due: 07/31/27

After Cesarean Time Interval for Exercise (ACTIVE) Trial

Phase: N/A Priority: Normal
NCT ID: NCT04345757 Org: User:
Start: 11/01/20 End: 08/01/25 Due: 08/01/26

Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients

Phase: N/A Priority: Normal
NCT ID: NCT00195052 Org: User:
Start: 05/31/02 End: 04/30/25 Due: 04/30/26

Mobile CBT for Middle Aged and Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT05754151 Org: User:
Start: 06/16/23 End: 06/30/27 Due: 06/30/28

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Phase: N/A Priority: Normal
NCT ID: NCT04021108 Org: User:
Start: 07/22/19 End: 06/30/26 Due: 06/30/27

Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals

Phase: N/A Priority: Normal
NCT ID: NCT05897619 Org: User:
Start: 09/19/23 End: 08/31/26 Due: 08/31/27

Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04402151 Org: User:
Start: 06/30/20 End: 12/31/27 Due: 12/31/28